Research Opportunities
We want to help kidney cancer researchers locate funding opportunities. We’ll update this page with grant opportunities as we learn about them. Know of one we haven’t listed? Email us at [email protected], or tweet at us, and we’ll get it posted!
KidneyCAN is dedicated to accelerating kidney cancer research.
Our advocacy for the DoD Kidney Cancer Research Program resulted in appropriations of $40 million in fiscal year 2020 for kidney cancer research. In 2016, this number was $0.
Our Kidney Cancer Research Summit brings translational researchers in kidney cancer together in an annual collaborative meeting. Additionally, KidneyCAN’s “Rock the Cure” events have raised over $1,000,000 toward private research support.
We are reaching out to you to create the best ideas yet for your KCRP proposal this year.
Please share this notice with other researchers in your network.
- Develop your ideas
- Build your team – even including members from other institutions
- Gather letters of support
- Review the grant mechanisms (including the new ones) and consider which would best support your idea
- Consider partnerships (including industry partnerships) and collaborations
FY21 KCRP Program Announcements Released
As new announcements are posted we will keep you updated.
Translational Research Partnership Award
Idea Development Award
Postdoctoral and Clinical Fellowship Award
AACR-MPM Oncology Charitable Foundation Transformative Cancer Research Grants
The AACR-MPM Oncology Charitable Foundation Transformative Cancer Research Grants represents a joint effort to stimulate “high-risk, high-reward” research from early- to mid-career investigators. This novel grant mechanism is intended to promote and support creative, paradigm-shifting cancer research that might not be funded through conventional channels. It is expected that these grants will catalyze significant scientific discoveries that will advance our understanding of cancer and have a potentially transformative impact on future clinical practice.
The application is due on September 30, 2021.
AACR: New Funding Opportunities
We’d love to see more RCC applicants for these prestigious grant opportunities. AACR has just updated their site with this note:
We hope you and your loved ones are well, given the difficult circumstances surrounding the COVID-19 pandemic. Please note that several funding opportunities are currently under development. Although we expect that the process may likely take longer than originally expected, please know that our team is working diligently to ensure that the new grants will be launched at the earliest possible date. We are closely monitoring the situation and will post upcoming funding opportunities here once a launch date has been confirmed.
However, if you have specific questions or concerns, please feel free to contact [email protected].
Sincerely,
The Scientific Review and Grants Administration Team
KidneyCAN is proud to present the 3rd Annual Kidney Cancer Research Summit on October 7 & 8, 2021. KCRS is a meeting focused on basic, translational, and clinical kidney cancer research. This meeting is fueled by the ideas and research funded through the Department of Defense CDMRP-KCRP awards.
The goal for KCRS is to present the important, innovative research funded by the KCRP. We also aim to connect researchers from around the world to share their work.
Kidney cancer is the ideal sandbox for these new approaches, and without a doubt the same approach can, should and will be suitable for other cancers.
Dr. Hans Hammers, UTSW
RESEARCH UPDATES
District Days 2021: Speaking with One Voice
Our Ask: Fund Kidney Cancer Research We lose almost 40 people per day to kidney cancer in the United States. The need for research funding is urgent.For District Days, the kidney cancer community met with members of Congress all over the United States to ask for...
Dr. John T. Wilson: “A Lot of Reason to Hope”
Researcher Spotlight: Dr. John T. Wilson Giving Patients "A Lot of Reason to Hope" At KidneyCAN, we have the pleasure of meeting and working with talented researchers from all over the world. We want to share some of the insights and experiences of one such researcher...
Advocating for Research Funding in DC: Show Us the Money!
On December 8th and 9th, KidneyCAN once again rallied our delgates to Washington, DC, to ask for Congress to fund kidney cancer research. This advocacy event was entirely virtual, conducted via phone calls and Zoom meetings. KidneyCAN advocates from all over the...
Join Our Grassroots Army
;
Privileged to present our work on papillary renal cell carcinoma models at #kcrs2021 @kidneycan in Philadelphia. What a vibrant, engaging and welcoming experience. @bcm_urology
WATCH: @PavlosMsaouel, @MDAndersonNews discusses how exercise can influence risk for patients with sickle cell trait to develop renal medullary carcinoma. @kidneycan #KCRS21 #kcsm http://ow.ly/Gx8J50Gq8YN
Terrific overview of mgmt of fav risk #kidneycancer by @TiansterZhang @utswcancer as a part of a spirited debate w @ERPlimackMD @FCUroOnc at @Lacog_group's Annual GU Review Mtg. Thx @DrAndreFay for the very kind invite! These mtgs makes me miss @PauloBergerot & @crisbergerot!
Choueiri Shares Highlights From the 2021 Kidney Cancer Research Summit @DrChoueiri @DanaFarber @harvardmed @kidneycan #KCRS21 #kcsm http://ow.ly/WgmS50GrHID
Next week! To all patients, family members and caregivers impacted by Kidney Cancer: our @df_hcc Kidney Cancer Symposium 10/22/2021. Email [email protected] to register! @DanaFarber @BIDMChealth @MGHCancerCenter @OncoAlert
Liquid biopsy-such an important topic for early detection!
Can't wait for this important conference! @isliquidbiopsy @ChristianRolfo ! https://twitter.com/isliquidbiopsy/status/1448616682415697934
Excited to share our integrative analysis of RMC at the single-cell level with dissection of mechanisms of cancer transformation & discovery of novel therapeutic targets. Such a team effort led by @biologyofben
! @PavlosMsaouel @KimrynRathmell @DrChoueiri
https://www.biorxiv.org/content/10.1101/2021.09.29.462391v1
Analysis Examines Real-World Survival Outcomes With Frontline Combos in Metastatic RCC @KevinZarrabi @FoxChaseCancer @kidneycan #KCRS21 #kcsm http://ow.ly/TJIT50GqLqU
WATCH: @ZakhariaYousef, of @UIowaCancer, discusses the role of seleno-L-methionine in previously treated advanced clear cell renal cell carcinoma. @kidneycan #KCRS21 #kcsm http://ow.ly/vsVi50Gpsst
What a great meeting!! Very well organized, very much patient centered and heavy on science, felt comfortable and safe despite pandemic .. thanks @kidneycan , looking forward to #KCRS22 https://twitter.com/BraunMDPhD/status/1446614506516385794
And that's a wrap. What a fantastic meeting #KCRS21 , then you @kidneycan @DrChoueiri @HHammersMD and all of the incredible patients and advocates
KidneyCAN is a registered 501(c)(3) nonprofit and does not receive any funding through the Congressionally Directed Medical Research Programs (CDMRP) or KCRP (Kidney Cancer Research Program). Our work is funded by grassroots donors in the kidney cancer community.
